Literature DB >> 10097003

Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain.

T J Coderre1, J Katz.   

Abstract

This target article examines the clinical and experimental evidence for a role of peripheral and central hyperexcitability in persistent pain in four key areas: cutaneous hyperalgesia, referred pain, neuropathic pain, and postoperative pain. Each suggests that persistent pain depends not only on central sensitization, but also on inputs from damaged peripheral tissue. It is instructive to think of central sensitization as comprised of both an initial central sensitization and an ongoing central sensitization driven by inputs from peripheral sources. Each of these factors, initial sensitization, ongoing central sensitization, and inputs from peripheral sources, contributes to the net activity in dorsal horn neurons and thus influences the expression of persistent pain or hyperalgesia. Since each factor, peripheral inputs and central sensitization (initial or ongoing), can contribute to both the initiation and maintenance of persistent pain, therapies should target both peripheral and central sources of pathology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10097003     DOI: 10.1017/s0140525x97251484

Source DB:  PubMed          Journal:  Behav Brain Sci        ISSN: 0140-525X            Impact factor:   12.579


  39 in total

1.  Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process.

Authors:  E Célèrier; J P Laulin; J B Corcuff; M Le Moal; G Simonnet
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain.

Authors:  Madhusudan Grover
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 3.  Sensitization, glutamate, and the link between migraine and fibromyalgia.

Authors:  Paola Sarchielli; Massimiliano Di Filippo; Katiuscia Nardi; Paolo Calabresi
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 4.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

5.  Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.

Authors:  Ya-Hsu Yang; Jen-Kou Lin; Wei-Shone Chen; Tzu-Chen Lin; Shung-Haur Yang; Jeng-Kai Jiang; Shih-Ching Chang; Yuan-Tzu Lan; Chun-Chi Lin; Chueh-Chuan Yen; Cheng-Hwai Tzeng; Wei-Shu Wang; Huey-Ling Chiang; Chung-Jen Teng; Hao-Wei Teng
Journal:  Support Care Cancer       Date:  2011-08-04       Impact factor: 3.603

6.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 7.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

8.  The evolution of primary hyperalgesia in orthopedic surgery: quantitative sensory testing and clinical evaluation before and after total knee arthroplasty.

Authors:  Valéria Martinez; Dominique Fletcher; Didier Bouhassira; Daniel I Sessler; Marcel Chauvin
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

Review 9.  Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Authors:  J Guindon; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 10.  An evidence-based algorithm for the treatment of neuropathic pain.

Authors:  Nanna B Finnerup; Marit Otto; Troels S Jensen; Søren H Sindrup
Journal:  MedGenMed       Date:  2007-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.